Sphingolipids in ischemic stroke
Keyword(s):
Determination of new biomarkers involved in the pathogenesis of ischemic stroke is an extremely important task from the point of view of identifying possible mechanisms for preventing the occurrence of an acute event, better diagnosis, and influencing the stages of pathogenesis to reduce the inflammatory focus. Sphingolipids belong to new biomarkers of atherosclerosis, which are involved in inflammation, apoptosis, and ischemia. The widespread introduction of mass spectrometry has made it possible to study sphingolipids in more detail. This review aims to summarize the available data on the role of sphingolipids in ischemic stroke.
2017 ◽
Vol 409
(28)
◽
pp. 6537-6547
◽
2007 ◽
Vol 90
(3)
◽
pp. 641-646
◽
Keyword(s):
1994 ◽
Vol 142
(2)
◽
pp. 251-259
◽
2017 ◽
Vol 1051
◽
pp. 84-91
◽
1999 ◽
Vol 18
(2)
◽
pp. 119-130
◽
2021 ◽
Vol 6
(2)
◽
pp. 71-81
Keyword(s):
1997 ◽
Vol 45
(3)
◽
pp. 325-339
◽
Keyword(s):